Current Report Filing (8-k)
16 September 2020 - 8:31PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): September 16, 2020
SIGMA
LABS, INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
001-38015
|
|
27-1865814
|
(State
or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification No.)
|
3900
Paseo del Sol
Santa
Fe, New Mexico 87507
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number, including area code: (505) 438-2576
Former
name or former address, if changed since last report
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.001 per share
|
|
SGLB
|
|
The
NASDAQ Stock Market LLC
|
Warrants
to Purchase Common Stock, par value $0.001 per share
|
|
SGLBW
|
|
The
NASDAQ Stock Market LLC
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth
company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
7.01 Regulation FD Disclosure.
Sigma
Labs, Inc. (the “Company”) from time to time makes presentations at conferences and to analysts, current stockholders,
potential investors and others, and has prepared presentation materials that the Company intends to use in this regard. A copy
of the presentation materials to be used is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein
by reference.
The
information contained in this Item 7.01 and in Exhibit 99.1 furnished herewith shall not be deemed “filed” for purposes
of Section 18 of the Exchange Act, or otherwise subject to the liabilities under Section 18 of the Exchange Act, nor shall it
be deemed incorporated by reference into any filings made by the Company under the Securities Act of 1933 or the Exchange Act,
except as shall be expressly set forth by specific reference in such a filing. The furnishing of this information will not be
deemed an admission as to the materiality of any information contained herein.
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
September 16, 2020
|
SIGMA LABS, INC.
|
|
|
|
|
By:
|
/s/
Mark K. Ruport
|
|
Name:
|
Mark
K. Ruport
|
|
Title:
|
President
and Chief Executive Officer
|
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Apr 2024 to May 2024
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From May 2023 to May 2024